TGA halted this process after stakeholders expressed a need for further clarification on some of the terms in the proposed policy. Inquiries came from industry representatives, care providers, governmental organizations, and consumers alike.

Here were the top requests of stakeholders:

  • Further clarification on the difference between how a custom-made device versus a patient-centric device is defined
  • The elimination of the proposed limit on the annual number of custom-made devices a manufacturer can supply, which could restrict patients’ access to the medical devices they need
  • Stricter definition of what is considered a “medical device production system,” as the environments within which medical devices are currently being manufactured are rapidly evolving and expanding

TGA agreed that its current proposed regulations are too broad and in need of improvement. The organization also stated that it “recognizes the need for further stakeholder engagement on this subject” and is presently accepting comments and recommendations from the public.

__

RegDesk is an A.I.-powered regulatory intelligence software that offers 24/7 access to the latest regulatory information for over 50 markets worldwide. Our platform eliminates the need for medical device companies to spend months gathering intelligence and preparing their registration applications. Through RegDesk’s centralized platform, clients can get access to product-specific registration requirements, expert answers to their most critical regulatory questions, and real-time alerts about global regulatory changes. To experience the power of RegDesk, contact us at desk@regdesk.co or visit www.regdesk.co.